Our results suggest that PTPN6 deficiency (assessed by IHC) occurs in 63% of all TCL tumors equally distributed across various TCL subtypes (62% PTCL-NOS, 42% AITL, and 60% ALK negative ALCL). The gene discussed is ALK; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.